Related Experiment Video
Updated: Jan 9, 2026

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
Multi-omics integration analysis based on plasma circulating proteins reveals potential therapeutic targets for
Jihai Zhou1, Wenwen Zhao1, Yiping Lin2
1Department of Gastroenterology, Shandong Provincial Maternal and Child Health Care Hospital Affiliated to Qingdao University, Jinan, China.
This study identifies four core genes (EIF5A2, IDO1, CDH5, MYL5) as potential biomarkers for ulcerative colitis (UC). Multi-omics analysis reveals their role in immune response and provides a diagnostic model for UC.
Area of Science:
- Gastroenterology
- Immunology
- Genomics
Background:
- Ulcerative colitis (UC) is a complex inflammatory bowel disease with unknown causes and difficult molecular mechanisms.
- Accurate diagnosis and effective treatment strategies for UC remain challenging.
Purpose of the Study:
- To identify potential diagnostic and therapeutic biomarkers for UC using multi-omics data integration.
- To gain new insights into the precise diagnosis and treatment of UC.
Main Methods:
- Integrated Gene Expression Omnibus and protein quantitative trait loci data to find overlapping genes.
- Employed machine learning algorithms to screen core hub genes and construct a diagnostic model.
- Validated findings using single-cell sequencing, immune infiltration analysis, and a DSS-induced UC mouse model.
Main Results:
- Identified 168 plasma proteins causally associated with UC and 12 overlapping genes.
- Discovered four core hub genes (EIF5A2, IDO1, CDH5, MYL5) with strong predictive performance for UC diagnosis.
- Revealed significant differences in immune cell infiltration and constructed a regulatory network, validated in a mouse model.
Conclusions:
- Systematically identified core diagnostic genes and their regulatory networks for UC through multi-omics integration.
- The identified genes and networks offer potential for precise diagnosis and targeted therapy development for UC.
More Related Videos
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...

